Industries

Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Revenue for the life sciences industry

Industry Supplement | March 2018

 

KPMG’s insights on ASC 606 implementation.  With the new revenue standard now in effect, KPMG reports on the most significant industry issues,  including updates in this March 2018 edition to clarify the latest thinking around the accounting for milestone payments.

Applicability

  • Companies in the life sciences industry

Relevant dates

Mandatory effective dates and early adoption provisions:

Annual periods:

For public business entities and certain not-for-profit entities the effective date for annual periods is the fiscal years beginning after Dec. 15, 2017.

For all other entites the effective date for annual periods is the fiscal years beginning after Dec. 15, 2018.

Interim periods:

For public business entities and certain not-for-profit entities the effective date for interim periods is the fiscal years beginning after Dec. 15, 2017.

For all other entites the effective date for interim periods is the fiscal years beginning after Dec. 15, 2019.

Early adoption:

For public business entities and certain not-for-profit entities the effective date for early adoption is the fiscal years beginning after Dec. 15, 2016.

For all other entites the effective date for early adoption is the fiscal years beginning after Dec. 15, 2016.

Key impacts

  • Rebates, discounts, chargebacks, price protection, outcomes-based pricing, milestone payments and rights of return will need to be estimated and may result in earlier recognition of revenue.
  • Companies applying sell-through accounting may recognize revenue earlier under the new standard.
  • Licenses of IP could have different accounting under the new standard, and significant judgment will be required to evaluate certain arrangements.
  • Entities need to evaluate whether a counterparty in a collaborative arrangement is a customer to determine if some or all of the arrangement is in the scope of the new standard.

Report contents

  • Specific issues for life sciences companies
  • Expanded disclosures
  • Effective dates and transition
  • Impact on the organization

Download the document:

Revenue for the life sciences industry

Download PDF

Explore more

Accounting Research Online

Access our accounting research website for additional resources for your financial reporting needs.

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.

Headline